Tikosyn and Rhinocort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tikosyn (dofetilide) and Rhinocort (budesonide). Common drug interactions include accident among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Tikosyn and Rhinocort. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Tikosyn?

Tikosyn has active ingredients of dofetilide. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 12,202 Tikosyn users. Check the latest studies of Tikosyn.

What is Rhinocort?

Rhinocort has active ingredients of budesonide. It is often used in allergies. eHealthMe is studying from 7,139 Rhinocort users. Check the latest studies of Rhinocort.



On Jul, 10, 2026

15 people who take Tikosyn and Rhinocort together, and have interactions are studied.

Tikosyn and Rhinocort drug interactions.

What are the common drug interactions of Tikosyn and Rhinocort, by gender? *:

female:

  1. Accident
  2. Blood cholesterol increased
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hypertension (high blood pressure)
  5. Urinary tract infection
  6. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  7. Breast cancer
  8. Dizziness
  9. Neoplasm malignant (cancer tumour)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Abdominal pain
  2. Diarrhoea
  3. Hypertension (high blood pressure)
  4. Mechanical complication of implant
  5. Weight increased
  6. Oesophageal disorder (disease of oesophagus)
  7. Blood pressure diastolic increased
  8. Headache (pain in head)
  9. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  10. Pain

What are the common drug interactions of Tikosyn and Rhinocort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Diarrhoea
  3. Oesophageal disorder (disease of oesophagus)
  4. Erythema (redness of the skin)
  5. Hypertension (high blood pressure)

50-59:

  1. Blood pressure diastolic increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Pain
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Device failure
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mechanical complication of implant
  9. Nasal obstruction (blockage of nose)
  10. Weight increased

60+:

  1. Accident
  2. Blood cholesterol increased
  3. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hypertension (high blood pressure)
  6. Urinary tract infection
  7. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  8. Breast cancer
  9. Dizziness
  10. Neoplasm malignant (cancer tumour)

What are the existing conditions these people have? *

  1. Sinus Disorder (disease of sinus): 5 people, 33.33%
  2. Corneal Disorder: 5 people, 33.33%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
  4. High Blood Pressure: 3 people, 20.00%
  5. Atrial Tachycardia (rhythm disturbance that arises in the atria): 3 people, 20.00%
  6. Acidosis (build-up of carbon dioxide in the blood): 3 people, 20.00%
  7. Arrhythmias (irregular heartbeat): 2 people, 13.33%
  8. Heart Failure: 1 person, 6.67%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.67%
  10. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tikosyn and Rhinocort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tikosyn and Rhinocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tikosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rhinocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tikosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rhinocort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dofetilide and budesonide (the active ingredients of Tikosyn and Rhinocort, respectively), and Tikosyn and Rhinocort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: